State University of New York at Buffalo — Buffalo, New York

State University of New York at Buffalo is a clinical research site located in Buffalo, New York, United States 14215.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

State University of New York at Buffalo has participated in 31 clinical trials with 11 currently active.

Therapeutic areas: Delayed Graft Function, Wound Infection, Tricuspid Regurgitation.

Sponsors: Angion Biomedica Corp, State University of New York at Buffalo, Edwards Lifesciences.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for State University of New York at Buffalo?

State University of New York at Buffalo has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has State University of New York at Buffalo conducted?

State University of New York at Buffalo has 31 clinical trials on record, with 11 currently active. Their work covers Delayed Graft Function, Wound Infection, Tricuspid Regurgitation.

Is State University of New York at Buffalo accredited by Crixeo Health?

State University of New York at Buffalo has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about State University of New York at Buffalo?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.